QoL · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
Summary of findings: Diet interventions showed no clear difference in QOL scores (IBDQ) (higher scores better) compared with usual on‐treatment diet (low certainty).
1 finding from 1 review
High‐fibre diet · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean GI symptom scores (Vaizey scale) (higher scores better) · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
Summary of findings: Diet interventions showed no clear difference in mean GI symptom scores (Vaizey scale) (higher scores better) compared with usual on‐treatment diet (low certainty).
1 finding from 1 review
Intervention not reported
Physical well‐being SF‐36 Physical Component Summary Score 0 to 100, higher scores indicate higher levels of physical well‐being Immediately post‐intervention · Cancer patients with cognitive impairment due to systemic cancer treatment
1 finding from 1 review
Intervention not reported
Physical well‐being SF‐36 Physical Component Summary Score 0‐100, higher scores indicate higher levels of physical well‐being Two‐months post‐intervention · Cancer patients with cognitive impairment due to systemic cancer treatment
1 finding from 1 review
Intervention not reported
Psychological well‐being SF‐36 Mental Component Summary Score 0 to 100, higher scores indicate higher levels of physical well‐being Immediately post‐intervention · Cancer patients with cognitive impairment due to systemic cancer treatment
1 finding from 1 review
Intervention not reported
Psychological well‐being SF‐36 Mental Component Summary Score 0 to 100, higher scores indicate higher levels of physical well‐being Two‐months post‐intervention · Cancer patients with cognitive impairment due to systemic cancer treatment
1 finding from 1 review
Overall survival · high‐grade glioma
Daily conventionally fractionated radiotherapy probably leads to higher overall survival compared with no radiotherapy (supportive care alone) (moderate certainty).
1 finding from 1 review
Adverse effects · high‐grade glioma
1 finding from 1 review
Progression‐free survival · high‐grade glioma
1 finding from 1 review
Quality of life · high‐grade glioma
1 finding from 1 review
Overall survival · high‐grade glioma
It is very uncertain whether hypofractionated radiotherapy changes overall survival compared with daily conventionally fractionated radiotherapy (very low certainty).
1 finding from 1 review
Adverse effects · high‐grade glioma
1 finding from 1 review
Progression‐free survival · high‐grade glioma
1 finding from 1 review
Quality of life · high‐grade glioma
1 finding from 1 review
Overall survival for subgroup age 60 years and older glioblastoma · high‐grade glioma
Hypofractionated radiotherapy showed no clear difference in overall survival for subgroup aged ≥ 60 years glioblastoma compared with daily conventionally fractionated radiotherapy (high certainty).
1 finding from 1 review
Pain ‐ Any grade · women with high‐grade VIN
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dose reductions · women with high‐grade VIN
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain ‐ Any grade · women with high‐grade VIN
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue · women with high‐grade VIN
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found